140 related articles for article (PubMed ID: 31226473)
1. Rabies virus glycoprotein (RVG29)-linked microRNA-124-loaded polymeric nanoparticles inhibit neuroinflammation in a Parkinson's disease model.
Gan L; Li Z; Lv Q; Huang W
Int J Pharm; 2019 Aug; 567():118449. PubMed ID: 31226473
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-124 regulates the expression of MEKK3 in the inflammatory pathogenesis of Parkinson's disease.
Yao L; Ye Y; Mao H; Lu F; He X; Lu G; Zhang S
J Neuroinflammation; 2018 Jan; 15(1):13. PubMed ID: 29329581
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic angiogenesis by local sustained release of microRNA-126 using poly lactic-co-glycolic acid nanoparticles in murine hindlimb ischemia.
Tsumaru S; Masumoto H; Minakata K; Izuhara M; Yamazaki K; Ikeda T; Ono K; Sakata R; Minatoya K
J Vasc Surg; 2018 Oct; 68(4):1209-1215. PubMed ID: 29242072
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-124 loaded nanoparticles enhance brain repair in Parkinson's disease.
Saraiva C; Paiva J; Santos T; Ferreira L; Bernardino L
J Control Release; 2016 Aug; 235():291-305. PubMed ID: 27269730
[TBL] [Abstract][Full Text] [Related]
5. Targeted brain delivery of itraconazole via RVG29 anchored nanoparticles.
Chen W; Zhan C; Gu B; Meng Q; Wang H; Lu W; Hou H
J Drug Target; 2011 Apr; 19(3):228-34. PubMed ID: 20540685
[TBL] [Abstract][Full Text] [Related]
6. Polymeric nanoparticles for the delivery of miRNA to treat Chronic Obstructive Pulmonary Disease (COPD).
Mohamed A; Kunda NK; Ross K; Hutcheon GA; Saleem IY
Eur J Pharm Biopharm; 2019 Mar; 136():1-8. PubMed ID: 30615927
[TBL] [Abstract][Full Text] [Related]
7. Targeted Brain Delivery of Rabies Virus Glycoprotein 29-Modified Deferoxamine-Loaded Nanoparticles Reverses Functional Deficits in Parkinsonian Mice.
You L; Wang J; Liu T; Zhang Y; Han X; Wang T; Guo S; Dong T; Xu J; Anderson GJ; Liu Q; Chang YZ; Lou X; Nie G
ACS Nano; 2018 May; 12(5):4123-4139. PubMed ID: 29617109
[TBL] [Abstract][Full Text] [Related]
8. Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease.
Wang S; Jing H; Yang H; Liu Z; Guo H; Chai L; Hu L
J Ethnopharmacol; 2015 Apr; 164():247-55. PubMed ID: 25666429
[TBL] [Abstract][Full Text] [Related]
9. Trans-blood brain barrier delivery of dopamine-loaded nanoparticles reverses functional deficits in parkinsonian rats.
Pahuja R; Seth K; Shukla A; Shukla RK; Bhatnagar P; Chauhan LK; Saxena PN; Arun J; Chaudhari BP; Patel DK; Singh SP; Shukla R; Khanna VK; Kumar P; Chaturvedi RK; Gupta KC
ACS Nano; 2015 May; 9(5):4850-71. PubMed ID: 25825926
[TBL] [Abstract][Full Text] [Related]
10. HPMA-PLGA Based Nanoparticles for Effective In Vitro Delivery of Rifampicin.
Rani S; Gothwal A; Pandey PK; Chauhan DS; Pachouri PK; Gupta UD; Gupta U
Pharm Res; 2018 Dec; 36(1):19. PubMed ID: 30511238
[TBL] [Abstract][Full Text] [Related]
11. [Inhibitory effects of Kukoamine B on the inflammatory response of small intestine in lipopolysaccharide-induced septic mice and its potential mechanisms].
Lyu W; Qin W; Zhang J; Shen W; Wang X; Sun B
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Feb; 27(2):121-6. PubMed ID: 25665611
[TBL] [Abstract][Full Text] [Related]
12. RVG29-modified microRNA-loaded nanoparticles improve ischemic brain injury by nasal delivery.
Hao R; Sun B; Yang L; Ma C; Li S
Drug Deliv; 2020 Dec; 27(1):772-781. PubMed ID: 32400219
[TBL] [Abstract][Full Text] [Related]
13. Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles.
Liu Y; Huang R; Han L; Ke W; Shao K; Ye L; Lou J; Jiang C
Biomaterials; 2009 Sep; 30(25):4195-202. PubMed ID: 19467700
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-146a Ameliorates Inflammation via TRAF6/NF-κB Pathway in Intervertebral Disc Cells.
Lv F; Huang Y; Lv W; Yang L; Li F; Fan J; Sun J
Med Sci Monit; 2017 Feb; 23():659-664. PubMed ID: 28161709
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-124-loaded nanoparticles increase survival and neuronal differentiation of neural stem cells in vitro but do not contribute to stroke outcome in vivo.
Saraiva C; Talhada D; Rai A; Ferreira R; Ferreira L; Bernardino L; Ruscher K
PLoS One; 2018; 13(3):e0193609. PubMed ID: 29494665
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory activity of chitosan nanoparticles carrying NF-κB/p65 antisense oligonucleotide in RAW264.7 macropghage stimulated by lipopolysaccharide.
Ma L; Shen CA; Gao L; Li DW; Shang YR; Yin K; Zhao DX; Cheng WF; Quan DQ
Colloids Surf B Biointerfaces; 2016 Jun; 142():297-306. PubMed ID: 26970817
[TBL] [Abstract][Full Text] [Related]
17. Anthocyanins encapsulated by PLGA@PEG nanoparticles potentially improved its free radical scavenging capabilities via p38/JNK pathway against Aβ
Amin FU; Shah SA; Badshah H; Khan M; Kim MO
J Nanobiotechnology; 2017 Feb; 15(1):12. PubMed ID: 28173812
[TBL] [Abstract][Full Text] [Related]
18. RVG29-modified docetaxel-loaded nanoparticles for brain-targeted glioma therapy.
Hua H; Zhang X; Mu H; Meng Q; Jiang Y; Wang Y; Lu X; Wang A; Liu S; Zhang Y; Wan Z; Sun K
Int J Pharm; 2018 May; 543(1-2):179-189. PubMed ID: 29555442
[TBL] [Abstract][Full Text] [Related]
19. MiR-150 predicts survival in patients with sepsis and inhibits LPS-induced inflammatory factors and apoptosis by targeting NF-κB1 in human umbilical vein endothelial cells.
Ma Y; Liu Y; Hou H; Yao Y; Meng H
Biochem Biophys Res Commun; 2018 Jun; 500(3):828-837. PubMed ID: 29689269
[TBL] [Abstract][Full Text] [Related]
20. miR-297 Protects Human Umbilical Vein Endothelial Cells against LPS-Induced Inflammatory Response and Apoptosis.
Yao Y; Jia H; Wang G; Ma Y; Sun W; Li P
Cell Physiol Biochem; 2019; 52(4):696-707. PubMed ID: 30921508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
